Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
Noriaki Ohuchi(Seirei Social Welfare Community), Jeffrey Schlom(National Cancer Institute), Renato Mariani‐Costantini(University of Chieti-Pescara), Jun Fujita(The University of Osaka), Masato Nose(Meiji University), Robert Callahan(National Institutes of Health), Ann D. Thor(University of Colorado Anschutz Medical Campus), Patricia Horan Hand(National Institutes of Health), Giorgio R. Merlo(University of Turin)
PubMed
March 1, 1987
Cited by 75
Related Papers
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
|Immunity|1999|2.7k
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Prognostic Factors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2000|1.1k